Project description
Theranostic nanoparticles against paediatric brain cancer
Theranostics is an emerging field of medicine that allows the combination of diagnosis, treatment and therapy follow-up. A theranostic approach for cancer therapy would reduce delays in treatment and offer a more targeted and personalised strategy. Importantly, it could be directed against tumours of the central nervous system that are otherwise hard to reach by standard chemotherapies. The EU-funded SUPERBRAIN project is developing a nanocapsule that combines a tumour-targeting molecule, a chemotherapeutic agent and photothermal therapy. The nanoparticles are magnetically guided in vivo, and they can be traced using imaging technologies. Moreover, they provide the opportunity to characterise the tumour and visualise the anatomy of the brain.
Fields of science
- natural sciencesbiological sciencesneurobiology
- medical and health sciencesbasic medicineanatomy and morphology
- medical and health sciencesclinical medicineoncology
- engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging
- natural sciencesphysical sciencesopticsspectroscopy
Programme(s)
Funding Scheme
MSCA-IF-EF-ST - Standard EFCoordinator
OX1 2JD Oxford
United Kingdom
See on map